Table 3.

Outcome

	3-month CCyR			6-month CCyR			12-month CCyR
	Yes	No	P	Yes	No	P	Yes	No	P
Total group
3-year EFS	98	83	< .001	97	72	< .001	98	67	< .001
3-year OS	99	95	.06	99	90	< .001	99	94	< .001
IM 400 mg
3-year EFS	92	81	.12	97	74	.001	98	72	< .001
3-year OS	100	88	.046	100	87	.09	100	88	.046
IM 800 mg
3-year EFS	97	84	.005	97	68	< .001	98	58	< .001
3-year OS	98	97	.93	99	92	.001	99	100	.03
Second TKI
3-year EFS	100	80	< .001	99	67	< .001	99	NA	NA
3-year OS	100	100	NA	100	100	NA	100	NA	NA
P (EFS/OS)	.07/.3			.56/.81			.9/.6

IM indicates imatinib; and NA, not applicable